Cargando…
The challenges in paediatric pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a rare, progressive disease affecting both adults and children. While overall survival has improved in recent years, the need for improved therapeutic approaches remains. Treatments for paediatric PAH have not yet been sufficiently examined, particularly rega...
Autores principales: | Beghetti, Maurice, Berger, Rolf M.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487412/ https://www.ncbi.nlm.nih.gov/pubmed/25445948 http://dx.doi.org/10.1183/09059180.00007714 |
Ejemplares similares
-
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
por: Rosenzweig, Erika B., et al.
Publicado: (2019) -
Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail
por: Berger, Rolf M. F., et al.
Publicado: (2019) -
A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE‐3
por: Berger, Rolf M. F., et al.
Publicado: (2017) -
Review of inhaled iloprost for the control of pulmonary artery hypertension in children
por: Tissot, Cecile, et al.
Publicado: (2009) -
A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years
por: Ivy, Dunbar, et al.
Publicado: (2020)